2009年
1. Aoki, K., Ito, Y., Saito, K., Shirakawa, J., Togashi, Y., Satoh, K., Muraoka, T., Shinoda, K., Masuda, K., Kimura, M., and Terauchi, Y. : Comparison of pre- versus post-meal administration of voglibose in men with or without impaired glucose tolerance. Diabetes Res. Clin. Pract., 83: e31-e32, 2009.
2. Arai, K., Hirao, K., Matsuba, I., Takai, M., Matoba, K., Takeda, H., Kanamori, A., Yamauchi, M., and Terauchi, Y. : The status of glycemic control by general practitioners and specialists for diabetes in Japan; A cross-sectional survey of 15,652 patients with diabetes mellitus. Diabetes Res. Clin. Pract., 83: 397-401, 2009.
3. Nakamura, A., Terauchi, Y., Ohyama, S., Kubota, J., Shimazaki, H., Nambu, T., Takamoto, I., Kubota, N., Eiki, J., Yoshioka, N., Kadowaki, T., and Koike, T. : Impact of small molecule glucokinase activator on glucose metabolism, cell function and mass. Endocrinology, 150: 1147-1154, 2009.
4. Aoki, K., Matsui, J., Kubota, N., Nakajima, H., Iwamoto, K., Takamoto, I., Tsuji, Y., Ohno, A., Mori, S., Tokuyama, K., Murakami, K., Asano, T., Aizawa, S., Tobe, K., Kadowaki, T., and Terauchi, Y. : The role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice. Am. J. Physiol. Endocrinol. Metab., 296: E842-853, 2009.
5. Watanabe, T., Kubota, N., Ohsugi, M., Kubota, T., Takamoto, I., Iwabu, M., Awazawa, M., Katsuyama, H., Hasegawa, C., Tokuyama, K., Moroi, M., Sugi, K., Yamauchi, T., Noda, T., Nagai, R., Terauchi, Y., Tobe, K., Ueki, K., and Kadowaki, T. : Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways. J. Biol. Chem., 284: 1803-1812, 2009.
6. Matsuda, S., Mikami, Y., Ohtani, M., Fujiwara, M., Hirata, Y., Minowa, A., Terauchi, Y., Kadowaki, T., and Koyasu, S. : Critical role of class IA PI3K for c-Rel expression in B lymphocytes. Blood, 113: 1037-1044, 2009.
7. Shirakawa, J., Takeshita, T., Miyao, M., Orimo, S, Terauchi, Y., and Mizuno, Y. : Pituitary abscess in a man with panhypopituitalism showing T1 signal hyper intensity of marginal pituitary area – An non invasive differential diagnosis of pituitary abscess and pituitary apoplexy- Intern. Med., 48: 441-446, 2009.
8. Goto, A., Takahashi, Y., Kishimoto, M., Minowada, S., Aibe, H., Hasuo, K., Kajio, H., and Noda, M. : Primary aldosteronism associated with severe rhabdomyolysis due to profound hypokalemia. Intern. Med., 48: 219-223, 2009.
9. Nakamura, A., Shimizu, C., Nagai, S., Nakagaki, O., Yoshida, M., Hida, Y., Aoki, K., Kondo, T., Miyoshi, H., Wada, N., Tajima, T., Terauchi, Y., Yoshioka, N, and Koike, T. : Problems in diagnosing atypical Gitelman’s syndrome presenting with normomagnesemia. Clin. Endocrinol., 2009 Jun 8. [Epub ahead of print]
10. Nozaki, Y., Fujita, K., Yoneda, M., Wada, K., Shinohara, Y., Takahashi, H., Kirikoshi, H., Inamori, M., Kubota, .K., Saito, S., Mizoue, T., Masaki, N., Nagashima, Y., Terauchi, Y., and Nakajima, A. : Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease. J. Heaptol., 51(3): 548-56, 2009.
11. Yamakawa, T., Ogihara, K., Nakamura, M., Utsunomiya, H., Kadonosono, K., Kishikawa, S., and Terauchi, Y. Effect of dehydroepiandrosterone on atherosclerosis in apolipoprotein E-deficient mice. J Atheroscler Thromb., 16(4): 501-8, 2009.
12. Okazaki, Y., Eto, K., Yamshita, T., Okamoto, M., Ohsugi, M., Noda, M., Terauchi, Y., and Kadowaki, T. Decreased insulin secretion and accumulation of triglyceride in -cells overexpressing a dominant-negative form of AMP-activated protein kinase. Endocr. J., 2009 Nov 19. [Epub ahead of print]
13. Goto, A., Takaichi, M., Kishimoto, M., Takahashi, Y., Kajio, H., Shimbo, T., and Noda, M. Body Mass Index, Fasting Plasma Glucose Levels, and C-peptide Levels as Predictors of the Future Insulin Use in Japanese Type 2 Diabetic Patients Endocr. J., 2009 Dec 23. [Epub ahead of print]
14. Kikuchi, K., Nezu, U., Shirakawa, J., Sato, K., Togashi, Y., Kikuchi, T., Aoki, K., Ito, Y., Kimura, M., and Terauchi, Y. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: Variations with levels of HbA1c Endocr. J., in press.
2008年
1. Iwasaki, T., Yoneda, M., Kawasaki, S., Fujita, K., Nakajima, A., and Terauchi, Y. Hepatic fat content-independent association of the serum level of gamma-glutamyltransferase with visceral adiposity, but not subcutaneous adiposity. Diabetes Res. Clin. Pract. 79(1): e13-14, 2008.
2. Iwasaki T, Togashi Y, Ohshige K, Yoneda M, Fujita K, Nakajima A., Terauchi Y : Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes. Diabetes Res. Clin. Pract. 79(3): 427-432, 2008.
3. Kawasaki, S., Aoki, K., Hasegawa, O., Numata, K., Tanaka, K., Shibata, N., Shimada, S., Okamura, A., and Terauchi, Y. Sonographic evaluation of visceral fat by measuring para- and perirenal fat. J. Clin. Ultrasound. 36: 129-133, 2008.
4. Goto, A., Takahashi, Y., Kishimoto, M., Tanabe, A., Kajio, H., Hasuo, K., and Noda, M. : Hypopituitarism caused by bilateral internal carotid artery aneurysms with a carotid-cavernous fistula. Intern. Med. 47(8): 815-816, 2008.
5. Iwasaki T, Togashi Y, Terauchi Y : Significant association of the serum albumin with the severity of retinopathy and neuropathy, in addition to that of nephropathy, in Japanese type 2 diabetic patients. Endocr. J. 55(2): 311-316, 2008.
6. Fujisawa, T., Nakajima, A., Fujisawa, N., Takahashi, H., Ikeda, I., Tomimoto, A., Yonemitsu, K., Nakajima, N., Kudo, C., Wada, K., Kubota, N., Terauchi, Y., Kadowaki, T., Nakagama, H., and Blumberg, R.S. : Peroxisome proliferator-activated receptor γ (PPARγ) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the β-catenin/T cell factor (TCF) pathway. J. Pharmacol. Sci. 106: 627-638, 2008.
7. Yano, W., Kubota, N., Itoh, S., Kubota, T., Awazawa, M., Moroi, M., Sugi, K., Takamoto, I., Ogata, H., Tokuyama, K., Noda, T., Terauchi, Y., Ueki, K., and Kadowaki, T. : Molecular mechanism of moderate insulin resistance in adiponectin-knockout mice. Endocr. J. 55(3): 515-522, 2008.
8. Takasawa, K., Kubota, N., Terauchi, Y., and Kadowaki, T. : Impact of increased PPARγ activity in adipocytes in vivo on adiposity, Insulin sensitivity and the effects of rosiglitazone treatment. Endocr. J. 55(4): 767-776, 2008.
9. Aoki, K., Tajima, T., Yabushita, Y., Nakamura, A., Nezu, U., Takahashi, M., Kimura, M., and Terauchi, Y. A novel initial codon mutation of the thiazide-sensitive Na-Cl cotransporter gene in a Japanese patient with Gitelman’s syndrome. Endocr. J. 55(3): 557-560, 2008.
10. Kubota, N., Kubota, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Mineyama, T., Ogata, H., Tokuyama, K., Ohsugi, M., Sasago, T., Moroi, M., Sugi, K., Kakuta, S., Iwakura, Y., Noda, T., Nagai, R., Tobe, K., Terauchi, Y., Ueki, K., and Kadowaki, T. : Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab. 8: 49-64, 2008.
11. Takamoto, I., Terauchi, Y., Kubota, N., Ohsugi, M., Ueki, K., and Kadowaki, T. : Crucial role of IRS-2 in compensatory β-cell hyperplasia in response to high-fat-diet-induced insulin resistance. Diabetes, Obesity and Metabolism 10 Suppl 4: 147-156, 2008.
12. Goto, A., Takahashi, Y., Kishimoto, M., Nakajima, Y., Nakanishi, K., Kajio, H., and Noda, M. :A Case of Fulminant Type 1 Diabetes Associated With Significant Elevation of Mumps Titers. Endocr. J. 55(3): 561-564, 2008.
13. Terauchi, Y. : Does the presence of metabolic syndrome as defined by the IDF guideline increase the risk of microvascular or macrovascular complications in patients with type 2 diabetes? (Commentary) International Atherosclerosis Society Website, July 18, 2008.
14. Aoki, K., Nakajima, S., Nezu, U., Shinoda, K., and Terauchi, Y. : Comparison of pre- versus post-meal administration of miglitol for 3 months in type 2 diabetic patients. Diabetes, Obesity, and Metabolism 10: 970-972, 2008.
15. Yamakawa, T., Takano, T, Tanaka, S.I., Kadonosono, K, and Terauchi, Y. : Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus. J. Atherosclerosis Thrombosis 15(5): 269-275, 2008.
16. Fujisawa, T., Sugiyama, M., Tomimoto, A., Wada, K., Endo, H., Takahashi, H., Yoneda, K., Yoneda, M., Inamori, M., Saito, S., Terauchi, Y., Kadowaki, T., Tsuchiya, N., Nakagama, H., and Nakajima, A. : Inhibition of Peroxisome Proliferator-Activated Receptor gamma promotes tumorigenesis through activation of the beta-catenin/TCF pathway in the mouse intestine. J. Pharmacol. Sci. 108: 535-544, 2008.
17. Fujita K, Nozaki Y, Yoneda M, Wada K, Takahashi H, Kirikoshi H, Inamori M, Saito S, Iwasaki T, Terauchi Y, Maeyama S, Nakajima A. : Nitric oxide plays a crucial role in the development/progression of nonalcoholic steathepatitis (NASH) in the choline deficient, l-amino acid-deficient (CDAA) diet-fed rat model. Alcohol Clin. Exp. Res., 2008 Oct 30. [Epub ahead of print]
18. Nezu, U., Nakamura, A., Aoki, K., Kimura, M., and Terauchi, Y. : Comparative study of effectiveness of multiple-daily injections of insulin versus twice-daily injections of biphasic insulin in patients with type 2 diabetes. Endocr. J., 2008 Nov 20. [Epub ahead of print]
2007年
1. Terauchi, Y., Takamoto, I., Kubota, N., Matsui, J., Suzuki,R., Komeda, K., Hara, A., Toyoda, Y., Miwa, I., Aizawa, S., Tsutsumi, S., Tsubamoto, Y., Hashimoto, S., Eto, K., Nakamura, A., Noda, M., Tobe, K., Aburatani, H., Nagai,R., and Kadowaki, T. Glucokinase and Irs2 are required for compensatory beta-cell hyperplasia in response to high-fat diet-induced insulin resistance. J. Clin. Invest. 117 : 246-257, 2007.
2. Yoneda, M., Iwasaki, T., Fujita, K., Kirikoshi, H., Inamori, M., Nozaki, Y., Maeyama, S., Wada, K., Saito, S., Terauchi, Y., and Nakajima, A. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus independently of visceral adipose tissue. Alcohol Clin. Exp. Res. 31 (Suppl 1): S15-S21, 2007.
3. Yamada,Y., Sekihara, H., Omura, M., Yanase, T., Takayanagi, R., Mune, T., Yasuda, K., Ishizuka, T., Ueshiba, H., Miyachi, Y., Iwasaki, T., Nakajima, A., and Nawata, H. Changes in serum sex hormone profiles after short-term low-dose administration of dehydroepiandrosterone (DHEA) to young and elderly persons. Endocr. J. 54 : 153-162, 2007.
4. Yoneda, M., Mawatari, H, Fujita, K., Yonemitsu, K., Kato, S., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., Abe, Y., Kubota, K., Saito, S., Iwasaki, T., Terauchi, Y., Togo, S., Maeyama, S, and Nakajima, A. Hypoadiponectinemia plays a crucial role in the deveopment of nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus independently of visceral adipose tissue. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. J. Gastroenterol. 42 : 375-381, 2007.
5. Fujita, K., Yoneda, M., Wada, K., Mawatari, H., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., Maeyama, S., Saito, S., Iwasaki, T., Terauchi, Y., and Nakajima A. Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats. Dig. Dis. Sci. 52: 3455-3464, 2007.
6. Aoki, K., Nakamura, A., Ito, S., Nezu, U., Iwasaki, T., Takahashi, M., Kimura, M., Terauchi, Y. Administration of miglitol until 30 minutes after the start of a meal is effective in type 2 diabetic patients. Diabetes Res. Clin. Pract. 78: 30-33, 2007.
7. Gerich, J.E., Odawara, M., and Terauchi, Y. The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk. Curr. Med. Res. Opin. 23: 1791-1798, 2007.
8. Kubota, N., Yano, W., Kubota, T., Yamauchi, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Okamoto, S., Shiuchi, T., Suzuki, R., Satoh, H., Tsuchida, A., Moroi, M., Sugi, K., Noda, T., Ebinuma, H., Ueta, Y., Kondo, T., Araki, E., Nagai, R., Tobe, K., Terauchi, Y., Ueki, K., Monikoshi, Y., and Kadowaki, T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 6: 55-68, 2007.
9. Iwasaki, T., Nakajima, A., Yoneda, M., and Terauchi, Y. Serum butyrylcholinesterase is strongly associated with adiposity, serum lipid profile, and insulin resistance. Intern. Med. 46: 1633-1639, 2007.
10. Yoneda, M., Mawatari, H., Fujita, K., Yonemitsu, K., Kato, S., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., Abe, Y., Kubota, K., Saito, S., Iwasaki, T., Terauchi, Y., Togo, S., Maeyama, S, and Nakajima, A. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J. Gastroenterol. 42: 573-582, 2007.
11. Kume, S., Uzu, T., Araki, S., Sugimoto, T., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Kubota, N., Terauchi, Y., Kadowaki, T., Haneda, M., Kashiwagi, A., and Koya, D. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet: Lessons from insulin-sensitive PPAR -deficient mice. J. Am. Soc. Nephrol. 18: 2715-2723, 2007.
12. Kaburagi, Y., Okochi, H., Satoh, S., Yamashita, R., Hamada, K., Ikari, K., Yamamoto-Honda, R., Terauchi, Y., Yasuda, K, and Noda, M. Role of IRS and PHIP on Insulin-Induced Tyrosine Phosphorylation and Distribution of IRS Proteins. Cell Struct. Funct. 32: 68-78, 2007.
13. Yoneda, M., Saito, S., Ikeda, T., Fujita, K., Mawatari, H., Kirikoshi, H., Inamori, M., Nozaki, Y., Akiyama, T., Takahashi, H., Abe, Y., Kubota, K., Iwasaki, T., Terauchi, Y., Togo, S., and Nakajima, A. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. J. Viral. Hepat. 14: 600-607, 2007.
14. Aoki, K., Kato, H., and Terauchi, Y. Divided-dose administration of miglitol just before and 15 minutes after the start of a meal smoothes the postprandial plasma glucose excursions and serum insulin responses in healthy men. Endocr. J. 54: 1009-1014, 2007.
15. Goto A, Kishimoto M, Takahashi Y, Kajio H, Noda M: Possible aggravation and recovery of slowly progressive type 1 diabetes by onset and resolution of oral and esophageal candidiasis. Intern. Med. 46: 1629, 2007.
2006年
1. Takeda, R., Nishimatsu, H., Suzuki, E., Satonaka, H., Nagata, D., Oba, S., Sata, M., Takahashi, M., Yamamoto, Y., Terauchi, Y., Kadowaki, T., Kangawa, K., Kitamura, T., Nagai, R., and Hirata, Y. Ghrelin improves renal function in mice with ischemic acute renal failure. J. Am. Soc. Nephrol. 17 : 113-121, 2006.
2. Kubota, N., Terauchi, Y., Kubota, T., Kumagai, H., Itoh, S., Satoh, H., Yano, W., Ogata, H., Tokuyama, K., Takamoto, I., Mineyama, T., Ishikawa, M., Moroi, M., Sugi, K., Yamauchi, T., Ueki, K., Tobe, K., Noda, T., Nagai, R., and Kadowaki, T. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J. Biol. Chem. 281 : 8748-8755, 2006.
3. Wada, K., Nakajima, A., Katayama, K., Kudo, C., Shibuya, A., Kubota, N., Terauchi, Y., Tachibana, M., Miyoshi, H., Kamisaki, Y., Mayumi, T., Kadowaki, T., and Blumberg, R.S. Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J. Biol. Chem. 281 : 12673-12681, 2006
4. Iwasaki, T., Nakajima, A., Yoneda, M., and Terauchi, Y. Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus. Endocr. J. 53 : 345-356, 2006
5. Muranaka, K., Yanagi, Y., Tamaki, Y., Usui, T., Kubota, K., Terauchi, Y., Kadowaki, T., and Araie, K. Effects of peroxisome proliferator-activated receptor g and its ligand on retinal leukocyte adhesion and retinal vascular leakage in a streptozotocin-induced diabetic model. Invest. Ophthalmol. Vis. Sci. 47: 4547-4552, 2006.
6. Kawasaki, S., Hasegawa, O., Satoh, S., Saito, T., Ishio, H., Fukushima, H., Kato, S., Yamashita, H., Terauchi, Y., and Sekihara, H. Development and progression of retinopathy after inpatient management of diabetes. Intern. Med. 45: 1267-1271, 2006.
7. Takano, T., Yamakawa, T., Takahashi, M., Kimura, M., and Okamura, A. Influences of statins on glucose tolerance in patients with type 2 diabetes mellitus. J. Atheroscler. Thromb. 13: 95-100, 2006.
8. Hayashi, H., Kanai, S., Yamada, Y., Tsushima, M., and Miyasaka, K. Acute inhibition of lymphatic cholesterol transport in rat intestine by SCH 58053. J. Atheroscler. Thromb. 13 : 240-246, 2006.
9. Shinoda, Y., Yamaguchi, M., Ogata, N., Akune, T., Kubota, N., Yamauchi, T., Terauchi, Y., Kadowaki, T., Takeuchi, Y., Fukumoto, S., Ikeda, T., Hoshi, K., Chung, U.I., Nakamura, K., and Kawaguchi, H. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J. Cell Biochem. 99: 196-208, 2006. (Review)
2005年
1. Iwasaki, T., Nakajima, A., Yoneda, M., Yamada, Y., Mukasa, K., Fujita, K., Fujisawa, N., Wada, K., and Terauchi, Y. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 28: 2486-2491, 2005.
2. Suzuki, R., Tobe, K., Aoyama, M., Sakamoto, K., Ohsugi, M., Kamei, N., Nemoto, S., Inoue, A., Ito, Y., Uchida, S., Hara, K., Yamauchi, T., Kubota, N., Terauchi, Y., and Kadowaki, T. Expression of DGAT2 in white adipose tissue is regulated by central leptin action. J. Biol. Chem. 280 : 3331-3337, 2005.
3. Yamaguchi, M., Ogata, N., Shinoda, Y., Akune, T., Kamekura, S., Terauchi, Y., Kadowaki, T., Hoshi, K., Ung-il Chung, U., Nakamura, K., and Kawaguchi, H. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice. Endocrinology 146 : 2620-2628, 2005.
4. Furumoto, T., Fujii, S., Onozuka, H., Zaman, A.K.M.T., Goto, D., Sugawara, T., Mikami, T., Watanabe, S., Abe, K., Terauchi, Y., Kadowaki, T., Kitabatake, A., Sobel, B.E. Loss of insulin receptor substrate-1 signaling induces the cardiovascular and proteo(fibrino)lytic system derangements typical of insulin resistance. Coron. Artery Dis. 16 : 117-123, 2005.
5. Lu, J., Imamura, K., Nomura, S., Mafune, K., Nakajima, A., Kadowaki, T., Kubota, N., Terauchi, Y., Ishii, G., Ochiai, A., Esumi, H., and Kaminishi, M. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice. Cancer Res. 65 : 4769-4774, 2005.
6. Zheng, Y., Yamada, H., Sakamoto, K., Horita, S., Kunimi, M., Endo, Y., Li, Y., Tobe, K., Terauchi, Y., Kadowaki, T., Seki, G., and Fujita, T. Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption. J. Am. Soc. Nephrol. 16: 2288-2295, 2005.
7. Iwasaki, T., Mukasa, K., Yoneda, M., Ito, S., Yamada, Y., Mori, Y., Fujisawa, N., Fujisawa, T., Wada, K., Sekihara, H., and Nakajima, A. Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone. Am. J. Physiol. Endocrinol. Metab. 288:E1222-8, 2005.
8. Inamori, M., Togawa, J., Iwasaki, T., Ozawa, Y., Kikuchi, T., Muramatsu, K., Chiguchi, G., Matsumoto, S., Kawamura, H., Abe, Y., Kirikoshi, H., Kobayashi, N., Shimamura, T., Kubota, K., Sakaguchi, T., Saito, S., Ueno, N., and Nakajima, A. Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use? J. Gastroenterol. 40:453-8, 2005.
9. Yamashita, R., Saito, T., Satoh, S., Aoki, K., Kaburagi, Y., and Sekihara, H. Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2. Endocr. J. 52:727-733, 2005
10. Terauchi, Y., and Kadowaki, T. Peroxisome proliferator-activated receptors and insulin secretion. Endocrinology 146: 3263-3265, 2005. (Review)
11. Kawaguchi, H., Akune, T., Yamaguchi, M., Ohba, S., Ogata, N., Chung, U.I., Kubota, N., Terauchi, Y., Kadowaki, T., and Nakamura, K. Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells. J. Bone Miner. Metab. 23 : 275-279, 2005. (Review)
12. Koyasu, S., Minowa, A., Terauchi, Y., Kadowaki, T., and Matsuda, S. The role of phosphoinositide-3-kinase in mast cell homing to the gastrointestinal tract. Novartis Found Symp. 271:152-161; discussion 161-165, 198-199, 2005. (Proceeding)